Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A randomized, double-blind, controlled phase II trial in advanced renal cell carcinoma (RCC) demonstrated synergistic anticancer effects with the combination of the glutaminase inhibitor telaglenastat (CB-839) and the mTOR inhibitor everolimus (TelaE), which was well tolerated by patients previously treated with TKIs
ALCAR also has a unique property of being able to cross the blood-brain barrier, where it acts as a powerful antioxidant, protecting neurons from damage caused by superoxide radicals
This product is not intended to cure or prevent any disease
High protein intake during energy deficit promotes greater lean mass retention
US$ 20.75
US$ 23.07
US$ 21.80
US$ 22.25
US$ 20.46
US$ 24.35
